Shire nabbed FDA approval for its new long-acting ADHD drug, becoming the second drugmaker in two days to win a nod in that field. Shire’s drug, Mydayis, has been a long time coming. Previously known ...

When Tales of the Shire was first announced, I was among the cozy gamers absolutely losing their minds with excitement. The game puts a wholesome, Hobbit-centric spin on a game set in Middle Earth. In ...

Looking for Tales of the Shire guides? Tales of the Shire is the Lord of the Rings game we never knew we needed. A cute, cozy farming sim like Stardew Valley or Animal Crossing, Tales of the Shire ...

Mirum Pharmaceuticals has bought the rights to maralixibat from Shire and raised $120 million to take it into a pair of phase 3 trials next year. The deal reunites some of the management team and ...

If there was ever a licensed property that feels right at home with a family-friendly farming simulator game, it’s The Lord of the Rings and author J.R.R. Tolkien’s iconic fantasy realm of ...

More than 30% of Shire’s (SHPG) total revenue for fiscal 2015 was from its ADHD (attention-deficit/hyperactivity disorder) portfolio. Major drugs in the portfolio ...

The history of one of the world's biggest speciality and rare disease pharmaceutical companies Shire is known as one of the world's fastest growing specialty pharmaceutical companies. Today, it has ...

Alice is a Lord of the Rings enthusiast who grew up with Tolkien's tales. She loves all kinds of writing, from articles to stories to her debut novel, which she is seeking literary representation for.

After six months of relentless pursuit, Shire SHPG finally announced that it will acquire Baxalta, Inc. BXLT for $32 billion. The boards of directors of both companies have agreed to the merger. We ...

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn't want to find stocks that are either flying under the radar and are ...

Often pegged as the only American in the Memphis Design Group—something that the 70-year-old visual artist and furniture designer dismisses as “a journalistic flourish” (he prefers to be singled out ...